Correlation Between Fluoguide and Combigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fluoguide and Combigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fluoguide and Combigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fluoguide AS and Combigene AB, you can compare the effects of market volatilities on Fluoguide and Combigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fluoguide with a short position of Combigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fluoguide and Combigene.

Diversification Opportunities for Fluoguide and Combigene

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Fluoguide and Combigene is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Fluoguide AS and Combigene AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Combigene AB and Fluoguide is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fluoguide AS are associated (or correlated) with Combigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Combigene AB has no effect on the direction of Fluoguide i.e., Fluoguide and Combigene go up and down completely randomly.

Pair Corralation between Fluoguide and Combigene

Assuming the 90 days trading horizon Fluoguide AS is expected to generate 0.93 times more return on investment than Combigene. However, Fluoguide AS is 1.08 times less risky than Combigene. It trades about 0.06 of its potential returns per unit of risk. Combigene AB is currently generating about 0.02 per unit of risk. If you would invest  3,850  in Fluoguide AS on April 22, 2025 and sell it today you would earn a total of  300.00  from holding Fluoguide AS or generate 7.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fluoguide AS  vs.  Combigene AB

 Performance 
       Timeline  
Fluoguide AS 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fluoguide AS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Fluoguide may actually be approaching a critical reversion point that can send shares even higher in August 2025.
Combigene AB 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Combigene AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Combigene is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Fluoguide and Combigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fluoguide and Combigene

The main advantage of trading using opposite Fluoguide and Combigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fluoguide position performs unexpectedly, Combigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Combigene will offset losses from the drop in Combigene's long position.
The idea behind Fluoguide AS and Combigene AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios